Repression of Multiple Myeloma Growth and Preservation of Bone With Combined Radiotherapy and Anti-Angiogenic Agent

Radiation Research - United States
doi 10.1667/rr1734.1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Radiation Research Society

Related search

Angiogenesis and Its Therapeutic Implication 5. Bone Marrow Angiogenesis and Anti-Angiogenic Therapy in Multiple Myeloma

Internal Medicine
Internal MedicineMedicine
2003English

Importance of the Bone Marrow Microenvironment in Inducing the Angiogenic Response in Multiple Myeloma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2006English

Combined Evaluation of Bone Marrow Aspirate and Biopsy Is Superior in the Prognosis of Multiple Myeloma

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2010English

Bone Destruction in Multiple Myeloma

Annals of the New York Academy of Sciences
GeneticsMolecular BiologyBiochemistryNeuroscienceHistoryPhilosophy of Science
2006English

Tetrac as an Anti-Angiogenic Agent in Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2019English

Frontal Skull Craniotomy Combined With Moderate-Dose Radiotherapy Effectively Ameliorate a Rare Case of Non-Secretory, Multiple Myeloma With Orbital Involvement

World Journal of Surgical Oncology
SurgeryOncology
2009English

Combined Treatment With a Transforming Growth Factor Beta Inhibitor (1D11) and Bortezomib Improves Bone Architecture in a Mouse Model of Myeloma-Induced Bone Disease

Bone
EndocrinologyPhysiologyHistologyMetabolismDiabetes
2016English

Multiple Myeloma With Advanced Bone Disease and Low Tumor Burden – Different Clinical Presentation but Similar Outcome After Bortezomib-Based Therapy and Radiotherapy

Acta Clinica Croatica
Medicine
2017English

Prevention of Radiation-Induced Bone Pathology Through Combined Pharmacologic Cytoprotection and Angiogenic Stimulation

Bone
EndocrinologyPhysiologyHistologyMetabolismDiabetes
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy